A new daily weight loss pill could be available soon – and a recent trial has shown that people taking the drug can shed ...

In the U.S. where adoption is highest, fewer than 1 in 10 adults are on a GLP-1 drug, despite nearly three-quarters being overweight or obese. Globally access is even more limited, held back by high ...

A weight loss pill called orforglipron has had some successful results from the human trial stage, so when could we see it on the NHS?

A trial of 3,127 patients who took a daily pill for 72 weeks saw an average weight loss per person of 12.3kg. While injectable obesity drugs are peptides designed to replicate the appetite-controlling ...